Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors

被引:62
作者
Disingrini, T
Muth, M
Dallanoce, C
Barocelli, E
Bertoni, S
Kellershohn, K
Mohr, K
De Amici, M
Holzgrabe, U
机构
[1] Univ Milan, Ist Chim Farmaceut & Tossicol, I-20131 Milan, Italy
[2] Univ Wurzburg, Inst Pharm, D-97074 Wurzburg, Germany
[3] Univ Bonn, Inst Pharm, D-53121 Bonn, Germany
[4] Univ Parma, Dipartimento Sci Farmacol Biol & Chim Appl, I-43100 Parma, Italy
关键词
D O I
10.1021/jm050769s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of muscarinic receptor ligands of the hexamethonio-type was prepared which contained, on one side, the phthalimidopropane or 1,8-naphthalimido-2,2-dimethylpropane moiety typical for subtype selective allosteric antagonists and, on the other, the acetylenic fragment typical for the nonselective orthosteric muscarinic agonists oxotremorine, oxotremorine-M, and related muscarinic agonists. Binding experiments in M-2 receptors using [H-3]N-methylseopolamine as an orthosteric probe proved an allosteric action of both groups of hybrids, 7a-10a and 8b-10b. The difference in activity between a-group and b-group hybrids corresponded with the activity difference between the allosteric parent compounds. In M-1-M-3 muscarinic isolated organ preparations, most of the hybrids behaved as subtype selective antagonists. [S-35]GTP gamma S binding assays using human M-2 receptors overexpressed. in CHO cells revealed that a weak intrinsic efficacy was preserved in 8b-10b. Thus, attaching muscarinic allosteric antagonist moieties to orthosteric muscarinic agonists may lead to hybrid compounds in which functions of both components are mixed.
引用
收藏
页码:366 / 372
页数:7
相关论文
共 47 条
[1]   New analogues of oxotremorine and oxotremorine-M - Estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes [J].
Barocelli, E ;
Ballabeni, V ;
Bertoni, S ;
Dallanoce, C ;
De Amici, M ;
De Micheli, C ;
Impicciatore, M .
LIFE SCIENCES, 2000, 67 (06) :717-723
[2]   Evidence for specific analgesic activity of a muscarinic agonist selected among a new series of acetylenic derivatives [J].
Barocelli, E ;
Ballabeni, V ;
Bertoni, S ;
De Amici, M ;
Impicciatore, M .
LIFE SCIENCES, 2001, 68 (15) :1775-1785
[3]   AN IMPROVED SYNTHESIS OF OXOTREMORINE [J].
BEBBINGT.A ;
SHAKESHA.D .
JOURNAL OF MEDICINAL CHEMISTRY, 1965, 8 (02) :274-&
[4]   Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors [J].
Bender, W ;
Staudt, M ;
Tränkle, C ;
Mohr, K ;
Holzgrabe, U .
LIFE SCIENCES, 2000, 66 (18) :1675-1682
[5]   Allosterism at muscarinic receptors: Ligands and mechanisms [J].
Birdsall, NJM ;
Lazareno, S .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) :523-543
[6]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[7]   Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery [J].
Christopoulos, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) :198-210
[8]   Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M [J].
Dallanoce, C ;
Conti, P ;
De Amici, M ;
De Micheli, C ;
Barocelli, E ;
Chiavarini, M ;
Ballabeni, V ;
Bertoni, S ;
Impicciatore, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (08) :1539-1547
[9]  
De Amici Marco, 2003, Farmaco (Lausanne), V58, P739, DOI 10.1016/S0014-827X(03)00113-7
[10]   Therapeutic, opportunities from muscarinic receptor research [J].
Eglen, RM ;
Choppin, A ;
Watson, N .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (08) :409-414